Items where authors include "Lord, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Jones, G.R.D., Bell, K.J.L., Ceriotti, F. orcid.org/0000-0002-0958-5354 et al. (5 more authors) (2024) Applying the Milan models to setting analytical performance specifications – considering all the information. Clinical Chemistry and Laboratory Medicine, 62 (8). pp. 1531-1537. ISSN 1434-6621

Baxter, M.A., Spender, L.C., Cairns, D. orcid.org/0000-0002-2338-0179 et al. (20 more authors) (2024) An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma. ESMO Open, 9 (5). 103450. ISSN 2059-7029

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Macaulay, V.M. orcid.org/0000-0001-8659-0192, Lord, S. orcid.org/0000-0001-7946-5609, Hussain, S. orcid.org/0000-0003-1552-511X et al. (11 more authors) (2023) A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer. British Journal of Cancer, 129 (6). pp. 965-973. ISSN 0007-0920

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Kemp, G.J., Birrell, F., Clegg, P.D. et al. (18 more authors) (2018) Developing a toolkit for the assessment and monitoring of musculoskeletal ageing. Age and Ageing, 47 (Supplement 4). iv1-iv19. ISSN 0002-0729

Del Din, S., Godfrey, A., Mazza, C. orcid.org/0000-0002-5215-1746 et al. (2 more authors) (2016) Free-living monitoring of Parkinson’s disease: lessons from the field. Movement Disorders, 31 (9). pp. 1293-1313. ISSN 0885-3185